PTLA - Portola Pharmaceuticals Inc.
Previous close
18.03
0 0%
Share volume: 0
Last Updated: Wed 01 Jul 2020 06:00:00 AM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$18.03
0.00
0.00%
Summary score
8%
Profitability
0%
Dept financing
37%
Liquidity
48%
Performance
0%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-794.78%
Return on assets
-16.7%
Return on sales
-826.43%
Return on invested capital
-104.81%
Total debt ratio
60.57%
Debt ratio change over timeo
-0.79%
Current Ratio
5.8%
Quick Ratio
5.51%
Cash Position Ratio
2.69%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-2834.68%
Return on assets
-12.68%
Return on sales
-213.61%
Return on invested capital
-95.78%
Total debt ratio
81.62%
Debt ratio change over timeo
-0.79%
Current Ratio
4.72%
Quick Ratio
4.69%
Cash Position Ratio
2.59%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-95.47%
Return on assets
-11.01%
Return on sales
-214.25%
Return on invested capital
-168.27%
Total debt ratio
85.97%
Debt ratio change over time
-1.12%
Current Ratio
4.87%
Quick Ratio
4.82%
Cash Position Ratio
2.49%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-405.03%
Return on assets
-105.36%
Return on sales
-258.37%
Return on invested capital
-29.96%
Total debt ratio
-78.64%
Debt ratio change over time
-0.79%
Current Ratio
0.95%
Quick Ratio
0.04%
Cash Position Ratio
-0.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | PTLA | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -794.78% | -7.13% | -82.7% | -27.35% |
Return on assets | -16.7% | -6.36% | -6.39% | -11.35% |
Return on sales | -826.43% | 0% | -592.81% | 0% |
Return on invested capital | -104.81% | -84.69% | -39.78% | 65.52% |
Profitability | 0% | 75% | 0% | 25% |
Total debt ratio | 60.57% | 15.45% | 89.22% | 38.11% |
Debt ratio change over time | -0.79% | -0.99% | -8.16% | -0.59% |
Dept financing | 17% | 4% | 25% | 36% |
Current Ratio | 4.72% | 11.45% | 3.37% | 10.41% |
Quick Ratio | 4.69% | 0% | 0% | 0% |
Cash Position Ratio | 2.59% | 6.31% | 2.81% | 5.11% |
Liquididy | 53% | 50% | 28% | 28% |
Short-term ratios | PTLA | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -2834.68% | -13.67% | -16.61% | -6.32% |
Return on assets | -12.68% | -12.16% | -6.02% | -5.59% |
Return on sales | -213.61% | 0% | 0% | 0% |
Return on invested capital | -95.78% | 4.61% | -30.98% | 34.2% |
Profitability | 0% | 3% | 25% | 75% |
Total debt ratio | 81.62% | 12.33% | 101.32% | 14.38% |
Debt ratio change over time | -0.79% | -1.02% | -9.66% | -0.83% |
Dept financing | 45% | 3% | 25% | 4% |
Current Ratio | 4.72% | 11.45% | 3.37% | 10.41% |
Quick Ratio | 4.69% | 0% | 0% | 0% |
Cash Position Ratio | 2.59% | 6.31% | 2.81% | 5.11% |
Liquididy | 46% | 50% | 18% | 43% |